SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-068172
Filing Date
2021-05-17
Accepted
2021-05-17 16:38:05
Documents
67
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2114119d1_10q.htm 10-Q 383578
2 EXHIBIT 31.1 tm2114119d1_ex31-1.htm EX-31.1 8862
3 EXHIBIT 31.2 tm2114119d1_ex31-2.htm EX-31.2 8908
4 EXHIBIT 32.1 tm2114119d1_ex32-1.htm EX-32.1 4328
5 EXHIBIT 32.2 tm2114119d1_ex32-2.htm EX-32.2 4249
  Complete submission text file 0001104659-21-068172.txt   3093275

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT scps-20210331.xml EX-101.INS 501399
7 XBRL TAXONOMY EXTENSION SCHEMA scps-20210331.xsd EX-101.SCH 49606
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scps-20210331_cal.xml EX-101.CAL 28068
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scps-20210331_def.xml EX-101.DEF 143666
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE scps-20210331_lab.xml EX-101.LAB 338926
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scps-20210331_pre.xml EX-101.PRE 284094
Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Filer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39788 | Film No.: 21931510
SIC: 2834 Pharmaceutical Preparations